Our research underscores the significant role of Cbl proto-oncogene (C-CBL) as a neddylation E3 ligase for IRS1 and IRS2, highlighting the promising potential of C-CBL as a target for regulating cancer metastasis in the context of insulin dysregulation. The gene discussed is IRS2; the disease is cancer.